Murad; Ferid

Patent Applications and Registrations

Patent applications and USPTO patent grants for Murad; Ferid.The latest application filed is for "formulations for treating metabolic syndrome and increasing energy levels".

Company Profile

1.7.10

Murad; Ferid - Menlo Park CA
Murad; Ferid - McLean VA
Murad; Ferid - Houston TX
Murad; Ferid - Lake Forest IL
Murad; Ferid - Los Altos Hills CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulations For Treating Metabolic Syndrome And Increasing Energy Levels App 20210038672 - Petrasek; Danny ; et al.	2021-02-11
Extended Production Of Nitric Oxide From A Microencapsulated Nitrite Salt And An Aqueous Acidified Gel App 20170065630 - Chen; Cheng-Shing ; et al.	2017-03-09
Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel Grant 9,445,996 - Chen , et al. September 20, 2	2016-09-20
Extended production of nitric oxide from microencapsulated chemical reactants Grant 8,980,331 - Chen , et al. March 17, 2	2015-03-17
Extended Production Of Nitric Oxide From A Microencapsulated Nitrite Salt And An Aqueous Acidified Gel App 20140056963 - Chen; Cheng-Shing ; et al.	2014-02-27
Extended Production Of Nitric Oxide From Microencapsulated Chemical Reactants App 20140056957 - Chen; Cheng-Shing ; et al.	2014-02-27
Regulation of sGC Function by Corrin Derivatives App 20100144675 - Martin; Emil ; et al.	2010-06-10
Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases App 20100035867 - Guerrant; Richard L. ; et al.	2010-02-11
Methods of detecting nitrotyrosine and aminotyrosine residues of peptides and proteins Grant 7,223,606 - Nedospasov , et al. May 29, 2	2007-05-29
Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using .alpha..beta..sup.Cys105 mutant sGC Grant 7,214,519 - Martin , et al. May 8, 2	2007-05-08
Methods of detecting nitrotyrosine and aminotyrosine residues of peptides and proteins App 20060035385 - Nedospasov; Andrei ; et al.	2006-02-16
Methods of detecting human diseases using a human genomic polynucleotide App 20050176043 - Murad, Ferid ; et al.	2005-08-11
Treatment or prevention of cGMP-dependent pathophysiology with a mutant variant of soluble guanylyl cyclase App 20040235079 - Martin, Emil ; et al.	2004-11-25
Genomic organization of mouse and human sGC App 20030096240 - Murad, Ferid ; et al.	2003-05-22
Guanidino compounds as regulators of nitric oxide synthase Grant 5,478,946 - Murad , et al. December 26, 1	1995-12-26
Guanidino compounds as regulators of nitric oxide synthase Grant 5,380,945 - Murad , et al. January 10, 1	1995-01-10
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same Grant 4,474,892 - Murad , et al. October 2, 1	1984-10-02

Company Registrations

SEC

0001228194

MURAD FERID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.